Learn how G-CSF and trilaciclib help prevent febrile neutropenia in extensive-stage SCLC, with NCCN-backed timing tips and ...
A recent study published in the Journal of the American Medical Association revealed that among patients with early-stage non ...
New guidance from the American College of Physicians (ACP) says all asymptomatic, average-risk females ages 50 to 74 should receive b ...
NAPT recognized Dr. Frank at the 2026 NPC with its Accelerator Award for Clinical Achievement, honoring exceptional clinicians who demonstrate leadership in proton therapy and play a pivotal role in ...
Morning Overview on MSN
New AI tool aims to predict small cell lung cancer treatment response
Researchers have built an AI-powered pathology tool designed to predict whether small cell lung cancer patients will respond ...
“I spent my entire career telling you about storms… Now I’m facing my own,” Nebraska meteorologist Kent Boughton said Vanessa Etienne is a Staff Writer for PEOPLE on the Health team. She joined the ...
The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution variant in pancreatic ductal adenocarcinoma, occurring in 40% of patients, ...
A benefit event will be held on June 13 to support Lorraine Falconer, currently undergoing treatment for incurable Small Cell ...
The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...
Results of a new study conclude that a pathology tool powered by artificial intelligence can predict whether a patient with ...
Findings Show Higher Levels of Th7R Immune Cells in the Blood, Suggesting Higher Response to Immunotherapy Due to R-1 EPS, a ...
The last time I spoke about Revolution Medicines (RVMD) it was with a Seeking Alpha article entitled "Revolution Medicines: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results